MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-24-0024853
Intermed Laboratories Private Limited
Intermed Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹112.88 Cr
▲ 22% YoY
Net profit · FY 2025
₹11.66 Cr
Net margin 10.3%
EBITDA · FY 2025
₹21.74 Cr
EBITDA margin 19.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹38.16 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
53
Provident fund records
About Intermed Laboratories Private Limited
Data last updated:
Intermed Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2019PTC331617. Its GSTIN is 27AASCA8228R1ZN (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Intermed Pharmaceuticals Private Limited. It is led by directors including Paresh Mehta Kirtilal and Rushabh Paresh Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 3 Floor – G A Todi Industrial Estate Sitaram Jadhav Marg Sun Mill Compound, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2025, the company reported a revenue of ₹112.88 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹11.66 Cr (net margin 10.3%) and EBITDA of ₹21.74 Cr (EBITDA margin 19.3%).
The company has about 53 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹38.16 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2022. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Khandoba Distilleries Private Limited with revenue of ₹113.2 Cr.
Intermed Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0024853).
Company details
CIN U24230MH2019PTC331617
Registration Number 331617
Incorporation Date 14 October 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-TN-24-0024853
Name history
Intermed Laboratories has undergone 3 name changes throughout its history. The company was previously known as Intermed Laboratories Private Limited, Intermed Pharmaceuticals Private Limited, and Azpire Pharma International Private Limited. The current legal name is Intermed Laboratories Private Limited.
| Company Name | Status |
|---|---|
| Intermed Laboratories Private Limited | Current |
| Intermed Pharmaceuticals Private Limited | Previous |
| Azpire Pharma International Private Limited | Previous |
Key People
Paresh Mehta Kirtilal Director Rushabh Paresh Mehta Director Riddhi Sahil Javeri Director Recognitions & Rankings of Intermed Laboratories
Contact details
Intermed Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 3 Floor – G A Todi Industrial Estate Sitaram Jadhav Marg Sun Mill Compound, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Intermed Laboratories Private Limited, buy the company report.
Comprehensive company report
Intermed Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Intermed Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Intermed Laboratories Private Limited, buy the company report.
Financials of Intermed Laboratories Private Limited
FY 2025 filings availableIntermed Laboratories Private Limited reported revenue of ₹112.88 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹112.88 Cr ▲ 22%
Net profit · FY 2025
₹11.66 Cr margin 10.3%
EBITDA · FY 2025
₹21.74 Cr margin 19.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 425%
5 years · compounded
▲ 737%
Revenue rose 22% in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.3% | ||||
| Net Profit Margin | 10.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Intermed Laboratories Private Limited, buy the company report.
Board of directors of Intermed Laboratories Private Limited
Intermed Laboratories has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Paresh Mehta Kirtilal Also directs: Intermed Life Sciences Private Limited, Kinshuk Developers Private Limited, Kuvam Realties Private Limited and 2 more | Director | 10 Aug 2021 | 5 Years 2 Months | Current |
| Rushabh Paresh Mehta Also directs: Intermed Life Sciences Private Limited | Director | 24 Aug 2021 | 5 Years 2 Months | Current |
| Riddhi Sahil Javeri Also directs: Intermed Life Sciences Private Limited, Unihealth Hospitals Limited, Azpire Pharma Private Limited and 1 more | Director | 14 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Intermed Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Khandoba Distilleries Private Limited | ₹113.2 Cr (FY 2025) | -15.0% | Pune, Maharashtra, India | |||
| Hindustan Poly Foams Private Limited | ₹112.99 Cr (FY 2025) | 9.0% | Delhi, India | |||
| Lab Sulphonate Private Limited | ₹112.98 Cr (FY 2025) | 17.0% | Udaipur, Rajasthan, India | |||
| Unimac Overseas Private Limited | ₹112.9 Cr (FY 2025) | -3.0% | New Delhi, Delhi, India | |||
| Stadmed Pvt Ltd | ₹112.88 Cr (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Intermed Laboratories Private Limitedthis company | ₹112.88 Cr (FY 2025) | ₹11.66 Cr | 10.3% | 22.0% | 53 | Mumbai, Maharashtra, India |
| CS Fine Interchem Private Limited | ₹112.74 Cr (FY 2025) | 18.0% | Vapi, Gujarat, India | |||
| Venkar Chemicals Private Limited | ₹112.58 Cr (FY 2024) | 61.0% | Hyderabad, Telangana, India | |||
| K B Chlorination Private Limited | ₹112.4 Cr (FY 2025) | 27.0% | Vadodara, Gujarat, India | |||
| Narendra Polymers Private Limited | ₹112.35 Cr (FY 2025) | -43.0% | New Delhi, Delhi, India | |||
| Shree Ganesh Remedies Limited | ₹112.33 Cr (FY 2025) | -13.0% | Anklesvar, Gujarat, India |
To see the full peer comparison of Intermed Laboratories Private Limited, buy the company report.
Auditor
Intermed Laboratories Private Limited is audited by JVJ & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JVJ & Co. | FY 2024 | 141427W |
Shareholding
The shareholding of Intermed Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Intermed Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹38.16 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jun 2025 | 101120428 | Yes Bank Limited | ₹1.21 Cr | Open | |
| 29 Oct 2021 | 100500888 | Yes Bank Limited | ₹36.95 Cr | Open |
To see the full charge records of Intermed Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Intermed Laboratories Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2022.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Intermed Laboratories Private Limited has 3 court cases on record: 3 filed by Intermed Laboratories. All cases are disposed.
Total cases
3
Filed by the company
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| Madras High Court | Writ petition | Filed by the company against an individual | Disposed |
To see the full case history of Intermed Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Intermed Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Intermed Laboratories Private Limited has a workforce of 53 employees on its EPFO records as of Feb 28, 2025, across 2 active EPFO establishments.
Employee count
53
Active EPFO establishments
2
Employee growth
-72.96%
GST
Intermed Laboratories has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AASCA8228R1ZN | Maharashtra | Active | 18 Oct 2019 |
| 33AASCA8228R1ZU | Tamil Nadu | Active | 25 Aug 2021 |
To see the full GST registrations and return filing status of Intermed Laboratories Private Limited, buy the company report.
Recent activity
Intermed Laboratories Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Paresh Mehta Kirtilal ceased to be Additional Director on 30 Nov 2021.
AGM
Intermed Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Yes Bank Limited amounted to Rs. 120.90 Lakh with Charge ID 101120428 was registered on 26 Jun 2025.
Filing
Intermed Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Yes Bank Limited of Rs. 3,694.73 Lakh registered on 29 Oct 2021 with Charge ID 100500888 was modified on 25 Feb 2025.
Ceased
Paresh Mehta Kirtilal ceased to be Additional Director.
Ceased
Rushabh Paresh Mehta ceased to be Additional Director.
Charges
A charge with Yes Bank Limited amounted to Rs. 3,694.73 Lakh with Charge ID 100500888 was registered on 29 Oct 2021.
Appointed
Rushabh Paresh Mehta was appointed as Director.
Appointed
Paresh Mehta Kirtilal was appointed as Director.
Ceased
Sahil Sagar Javeri ceased to be Director.
Appointed
Riddhi Sahil Javeri was appointed as Director.
Incorporation
14 Oct 2019
Intermed Laboratories Private Limited was registered on 14 Oct 2019 with Roc Mumbai & aged 7 years 14 days as per MCA records.
Frequently asked questions
Intermed Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 October 2019 (7+ years old) and is registered under CIN U24230MH2019PTC331617.
Intermed Laboratories has 3 current directors:
- Paresh Mehta Kirtilal - Director
- Rushabh Paresh Mehta - Director
- Riddhi Sahil Javeri - Director
The latest financial statements of Intermed Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Intermed Laboratories is 27AASCA8228R1ZN, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AASCA8228R1ZU (Tamil Nadu).
The CIN (Corporate Identification Number) of Intermed Laboratories is U24230MH2019PTC331617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intermed Laboratories has 3 court cases on record: 3 filed by the company.
Intermed Laboratories was incorporated on 14 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Intermed Laboratories has 1 deal on record (1 secondary share transfer); the latest was in March 2022.
The peers of Intermed Laboratories by revenue are Khandoba Distilleries Private Limited, Hindustan Poly Foams Private Limited, Lab Sulphonate Private Limited, Unimac Overseas Private Limited, Stadmed Pvt Ltd and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Paresh Mehta Kirtilal ceased to be Additional Director on 30 Nov 2021. Rushabh Paresh Mehta ceased to be Additional Director on 30 Nov 2021. Rushabh Paresh Mehta was appointed as Director on 24 Aug 2021. Intermed Laboratories has 6 board changes on record in total.
Yes, Intermed Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-24-0024853).